GlassScriptPhysician profile
Ashley Lwin
NPI 1023726544
$659.33
in general payments reported to CMS, 2019-2025
11 companies · $34.05 in 2025
The $34.05 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $374 · 2024: $252 · 2025: $34.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $293.29 | 2023-2025 | |
| Novo Nordisk INC | $83.25 | 2023-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $73.36 | 2023-2024 | Mounjaro, Zepbound, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $52.76 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $27.37 | 2023 | Breztri, Farxiga |
| Pfizer INC. | $24.93 | 2023 | |
| Idorsia Pharmaceuticals US INC | $23.70 | 2024 | Quviviq |
| Janssen Pharmaceuticals, INC | $23.37 | 2023 | Spravato |
| Vivus LLC | $19.52 | 2024 | Qsymia |
| Takeda Pharmaceuticals U.S.A., INC. | $19.39 | 2024 | Trintellix |
| Exact Sciences Corporation | $18.39 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Lwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.